Dr. Alvin G. Wee, Elected Education & Research Division Director of the American College of Prosthodontists
/
Date19 Dec 2016
Dr. Wee CHICAGO, Dec. 19, 2016 (GLOBE NEWSWIRE) — Dr. Alvin G. Wee, DDS, M.S., M.P.H., Ph.D. was elected the Education & Research Division Director... Read More →
Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study
/
Date19 Dec 2016
LipimetiX Cyno Monkey Data-Dec 2016.pdf TEMPE, Ariz., Dec. 19, 2016 (GLOBE NEWSWIRE) — Capstone Therapeutics Corp. (OTCQB:CAPS) (“the Company”) and LipimetiX Development, Inc., the Company’s... Read More →
Novo Nordisk A/S – Share repurchase programme
/
Date19 Dec 2016
Company Announcement No. 88 / 2016.pdf Bagsværd, Denmark, 19 December 2016 – On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance... Read More →
Endologix Receives Australian Therapeutic Goods Administration (TGA) Approval for AFX®2 Bifurcated Endograft System
/
Date19 Dec 2016
IRVINE, Calif., Dec. 19, 2016 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the Australian... Read More →
Novo Nordisk A/S – aktietilbagekøbsprogram
/
Date19 Dec 2016
Selskabsmeddelelse nr. 88 / 2016.pdf Bagsværd, 2016-12-19 – Den 28. oktober 2016 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og... Read More →
Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424
/
Date19 Dec 2016
— Preclinical studies will explore the effects of TH-3424 against T-cell acute lymphoblastic leukemia cancer cell lines with high AKR1C3 expression — SOUTH SAN FRANCISCO,... Read More →
Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel
/
Date19 Dec 2016
SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) — Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the 510(k) submission for the... Read More →
Holiday Gift Guide for Those Living With Diabetes Now Available
/
Date19 Dec 2016
NEW YORK, Dec. 19, 2016 (GLOBE NEWSWIRE) — Lyfebulb, an organization focused on bringing innovative products and solutions to market for those living with chronic disease and creator of... Read More →
Antares Pharma Announces the Successful Completion of Teva’s Decentralized Procedure for Teriparatide Injection in Europe
/
Date19 Dec 2016
EWING, N.J., Dec. 19, 2016 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Teva Pharmaceutical Industries, Ltd. (Teva) has successfully concluded a decentralized... Read More →
MediciNova Announces Phase 2b Trial of MN-166 (ibudilast) in Progressive MS will Continue as Planned Following DSMB Review of Interim Efficacy Analysis
/
Date19 Dec 2016
LA JOLLA, Calif., Dec. 19, 2016 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market... Read More →